医学
肾脏疾病
心脏病学
内科学
肺动脉高压
透析
肾功能
血管阻力
血液透析
高血压的病理生理学
血压
重症监护医学
作者
A. Travers,Harrison W. Farber,Mark J. Sarnak
标识
DOI:10.1016/j.ccl.2021.04.004
摘要
There is a high prevalence of pulmonary hypertension in chronic kidney disease (CKD), with rates increasing as glomerular filtration rate declines. Pulmonary hypertension is associated with a higher risk of cardiovascular events and mortality in non-dialysis-dependent CKD stages 3 to 5, dialysis-dependent CKD, as well as kidney transplant recipients. The pathophysiology of pulmonary hypertension in CKD is multifactorial and includes higher pulmonary capillary wedge pressure caused by ischemic heart disease and cardiomyopathy, higher cardiac output caused by anemia and arteriovenous access used for hemodialysis, as well as potentially higher pulmonary vascular resistance. Treatment should focus on the underlying cause.
科研通智能强力驱动
Strongly Powered by AbleSci AI